Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / India / Novo Nordisk

India & Novo Nordisk

5 shared events · Importance 3 · Last updated Apr 03, 2026

Importance
3
Shared Events
5
Actions
0
Sentiment
23.333333333333332
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (5)
84
Business
Novo Nordisk Cuts Wegovy Price in India
India: India is a key battleground for weight-loss drugs due to its large obesity population and is experiencing significant competition between Novo Nordisk and Eli Lilly and Company.
Novo Nordisk: Novo Nordisk cut the price of its weight-loss drug Semaglutide in India to compete with Eli Lilly and prepare for generic competition, aiming to increase market share and accessibility.
Nov 11, 2025 · 6 articles
0
Business
Novo Nordisk, Emcure Partner for Poviztra
Novo Nordisk: Novo Nordisk partnered with Emcure Pharma to expand the distribution and marketing of its weight-loss drug semaglutide in India under the brand Poviztra, aiming to reach a wider population.
Nov 10, 2025 · 6 articles
0
Regulatory
India's Weight-Loss Drug Misuse
Apr 03, 2026 · 8 articles
0
Business
Novo Nordisk Cuts Ozempic, Wegovy Prices in India
Mar 30, 2026 · 8 articles
0
Business
Novo Nordisk Semaglutide Patent Expiry in India
Mar 20, 2026 · 8 articles
NEWSDESK
Explore this relationship live

Track how India and Novo Nordisk interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.